Stocks and Investing Stocks and Investing
Fri, August 10, 2018
Thu, August 9, 2018
Wed, August 8, 2018
Tue, August 7, 2018
Mon, August 6, 2018
Fri, August 3, 2018

David Risinger Maintained (TEVA) at Hold with Increased Target to $20 on, Aug 3rd, 2018


Published on 2024-10-26 07:38:26 - WOPRAI, David Risinger
  Print publication without navigation


David Risinger of Morgan Stanley, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold with Increased Target from $19 to $20 on, Aug 3rd, 2018.

David has made no other calls on TEVA in the last 4 months.



There are 4 other peers that have a rating on TEVA. Out of the 4 peers that are also analyzing TEVA, 3 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Louise Chen of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $25 on, Monday, July 16th, 2018
  • Jacob Hughes of "Wells Fargo" Upgraded from Sell to Hold on, Monday, June 18th, 2018
  • Douglas Tsao of "Barclays" Maintained at Hold with Increased Target to $20 on, Thursday, May 24th, 2018


This is the rating of the analyst that currently disagrees with David


  • Liav Abraham of "Citigroup" Maintained at Strong Buy with Increased Target to $25 on, Thursday, May 31st, 2018